In the present study, plasma levels of SOD1 and SOD2 in patients with CAD (both SAP and ACS) were higher than those in healthy controls, which is consistent with a previous study [13], assuming that higher plasma SOD levels correlate with higher SOD activity. This evidence concerns the gene SOD2 and coronary artery disorder.